Package Insert: Information for the User
Tradonal Retard 150 mg Extended-Release Hard Capsules
tramadol hydrochloride
Read this package insert carefully before starting to take this medication, as it contains important information for you.
6. Contents of the pack and additional information
Tradonal retard belongs to a group of medications called analgesics, commonly known as pain-relieving medications. The active substance, tramadol hydrochloride, interrupts the pain messages sent to the brain and also acts on the brain to prevent the pain messages from being felt. This means that the medication does not prevent the pain from occurring, but rather you will not be able to feel the pain as much.
Tradonal retard is used to relieve moderate to severe pain (for example, pain after surgery, or after an injury).
Do not take Tradonal retard
Warnings and precautions
Consult your doctor or pharmacist before starting to take Tradonal retard:
Respiratory problems related to sleep
This medication may cause respiratory problems related to sleep, such as central sleep apnea (pause in breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood). These symptoms may include pause in breathing during sleep, nocturnal awakening due to difficulty breathing, difficulty maintaining sleep, or excessive daytime somnolence. If you or someone else observes these symptoms, consult your doctor. Your doctor may consider reducing the dose.
Inform your doctor if you experience any of the following symptoms while taking Tradonal retard:
Extreme fatigue, loss of appetite, severe abdominal pain, nausea, vomiting, or low blood pressure. This may indicate that you have adrenal insufficiency (low cortisol levels). If you experience any of these symptoms, inform your doctor, who will decide whether you should take a hormonal supplement.
There is a rare possibility that this medication may cause seizures (attacks). This risk increases if you take higher-than-recommended doses and also take antidepressants or antipsychotics.
Tolerance, dependence, and addiction
This medication contains tramadol, which is an opioid medication. Repeated use of opioids can make the medication less effective (the body becomes accustomed to it, known as pharmacological tolerance). Repeated use of this medication can also cause dependence, abuse, and addiction, which could lead to a potentially fatal overdose. The risk of these adverse effects may be higher with a higher dose and longer use.
Dependence or addiction can cause a feeling of lack of control over the amount of medication you should use or the frequency with which you should use it.
The risk of dependence or addiction varies from person to person. The risk of becoming dependent or addicted to this medication may be higher if:
If you observe any of the following symptoms while using this medication, it could be a sign of dependence or addiction:
If you notice any of these signs, consult your doctor to determine the best course of treatment for you, when it is appropriate to discontinue the medication, and how to do so safely (see section 3, "If you interrupt treatment with Tradonal retard").
Do not take this medication to treat withdrawal symptoms in cases of addiction to medications.
There is a weak risk that you may experience a serotonin syndrome that can occur after taking tramadol in combination with certain antidepressants or tramadol alone. Consult your doctor immediately if you experience any of the symptoms associated with this severe syndrome (see section 4 "Possible side effects").
Tramadol is metabolized in the liver by an enzyme. Some people have a variation of this enzyme, and it can affect each person differently. In some people, it may not be possible to achieve sufficient pain relief, while others may be more likely to experience severe adverse effects. If you experience any of the following adverse effects, stop taking this medication and consult your doctor immediately: shallow or slow breathing, confusion, drowsiness, constricted pupils, feeling of dizziness, constipation, loss of appetite.
In rare cases, increasing the dose of this medication may make you more sensitive to pain. If this occurs, discuss your treatment with your doctor.
Children and adolescents
This medication should not be used in children under 12 years old.
Use in children with respiratory problems
Tramadol should not be used in children with respiratory problems, as the symptoms of tramadol toxicity may worsen in these children.
Other medications and Tradonal retard
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including those purchased without a prescription.
Do not take Tradonal retard at the same time, or during the 14 days after taking medications called monoamine oxidase inhibitors (moclobemide or phenelzine for depression, selegiline for Parkinson's disease).
The pain relief produced by tramadol may be weakened or shortened if you also take medications that contain:
Your doctor will indicate whether you should take this medication and at what dose.
The risk of adverse effects increases if you are taking medications that facilitate or may cause seizures, such as certain antidepressants or antipsychotics. The risk of seizures increases if you take Tradonal retard simultaneously with these medications. Your doctor will indicate whether it is suitable for you.
The risk of adverse effects increases if you are taking antidepressants. Tradonal retard may interact with these medications and may experience a serotonin syndrome (see section 4 "Possible side effects").
Medications that act on the nervous system, such as hypnotics, tranquilizers, sleeping pills, and analgesics, may make you feel more sleepy or weak if you use them with tramadol.
The risk of adverse effects increases if you are taking gabapentin or pregabalin to treat epilepsy or pain due to nerve problems (neuropathic pain).
Anticoagulants to thin your blood, such as warfarin. The effectiveness of these medications may be altered if taken with tramadol.
Inform your doctor if you are taking these medications.
The concomitant use of tramadol with sedatives, such as benzodiazepines or related substances, increases the risk of somnolence, respiratory depression, and coma and may be potentially fatal. Therefore, concomitant use should only be considered when other options are not possible.
However, if your doctor prescribes Tradonal retard together with sedatives, the dose and duration of concomitant treatment will be limited by your doctor.
Inform your doctor of all sedatives you are taking and take exactly the dose your doctor recommends. It is helpful to inform your friends or family members to be alert to the appearance of the symptoms and signs explained above. Contact your doctor if you experience these symptoms.
Tradonal retard with food, drinks, and alcohol
This medication should be taken with a little water, with or without food. Avoid drinking alcohol while taking this medication.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medication. Contact your doctor if you become pregnant during your treatment.
Pregnancy
Tradonal retard should not be taken during pregnancy or during breastfeeding. This is because it is not yet known how safe it is to take this medication when pregnant. Contact your doctor if you become pregnant during your treatment.
Breastfeeding
Tramadol is excreted in breast milk. Therefore, you should not take Tradonal retard more than once during breastfeeding, or if you take this medication more than once, you should stop breastfeeding.
Driving and operating machinery
Tradonal retard may cause drowsiness, and this effect may be potentiated by alcohol, antihistamines, and other central nervous system depressants. If patients are affected, they should be advised not to drive or operate machinery.
Tradonal retard contains saccharose
If your doctor has indicated that you have an intolerance to certain sugars, consult with him before taking this medication.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Before starting treatment and regularly during it, your doctor will also explain what you can expect from the use of Tradonal retard, when and for how long you should use it, when you should contact your doctor and when you should suspend use (see also section 2).
The dose should be adjusted to the intensity of the pain and your individual sensitivity to pain. Normally, the lowest dose that produces pain relief should be taken.
The modified-release capsules of Tradonal retard are packaged in a child-resistant laminate to ensure safety.
The child-resistant laminate is more resistant, making it more difficult to push the capsules through it.
Perforate the laminate beforehand and then push the capsule to remove it from the blister, in order to avoid damaging the capsules.
Swallow the capsules whole, without chewing, with a little water.
If you have difficulty swallowing the capsules, you can open them. You must open them carefully, pulling and turning at the same time, over a spoon, so that the granules remain on the spoon. Do not chew them. Swallow the granules with water.
Dose for adults and adolescents 12 years and older
The usual initial dose is 50-100 mg twice a day, in the morning and at night. Your doctor may increase this dose to 150-200 mg twice a day, according to the intensity of the pain and your needs. Normally, you should take the medication every 12 hours, at the same time in the morning and at night.
Theusual maximumdose is 400 mg per day.
Use in children
This medication should not be administered to children under 12 years old.
Use in elderly patients
In elderly patients (over 75 years old), the elimination of tramadol may be slow. If this happens, your doctor may recommend increasing the interval between doses.
Use in patients with liver or kidney disease/patients on dialysis
If you have any severe liver and/or kidney disease, treatment with this medication is not recommended. If you have moderate liver or kidney disease, your doctor may prolong the dosing intervals.
If you take more Tradonal retard than you should
If you have accidentally taken more capsules than the dose indicated, inform your doctor or pharmacist immediately and, if necessary, contact your nearest hospital. Remember to bring the packaging and any remaining medication with you.
In case of overdose or accidental ingestion, consult the Toxicological Information Service, phone 91 562 04 20, or go immediately to a hospital.
If you forgot to take Tradonal retard
Do not take a double doseto compensate for the missed doses.
If you interrupt treatment with Tradonal retard
Do not stop treatment with this medication suddenly, unless your doctor tells you to. If you want to stop taking this medication, consult your doctor first, especially if you have been taking it for a long time. Your doctor will advise you when and how to stop treatment, which may be done by gradually reducing the dose, to reduce the risk of adverse effects (withdrawal symptoms).
People who have been taking this medication for some time may feel unwell if they stop taking it suddenly. They may feel agitated, anxious, nervous or shaky. They may be hyperactive, have difficulty sleeping and have gastrointestinal or intestinal disorders. Consult your doctor if you experience any of these symptoms after stopping this medication.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The most serious side effects that may occur include an allergic reaction (difficulty breathing, wheezing, and swelling of the face or throat), anaphylactic reaction (extreme allergic reaction causing difficulty breathing, changes in heart rate, weakness, collapse, or loss of consciousness due to a drop in blood pressure) or seizures (attacks). If you have any of these symptoms, stop taking this medicine immediately and seek medical advice.
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency not known (cannot be estimated from available data)
Withdrawal symptomsinclude: agitation, anxiety, nervousness, difficulty sleeping, restlessness, tremors, and gastrointestinal problems (see section 3 "How to take Tradonal retard").
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Medications should not be disposed of through drains or trash. Dispose of packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
The active ingredient is hydrochloride of tramadol.
Each capsule contains 150 mg of hydrochloride of tramadol.
The other components (excipients) of the capsule content are:sugar spheres (sucrose and cornstarch),anhydrous colloidal silica,cellulose,gum,talc.
The capsule contains:gelatin,titanium dioxide (E 171),yellow iron oxide (E 172),indigotin(E 132).
The printing ink contains: gum, iron oxide black (E 172), propylene glycol, ammonium hydroxide.
Appearance of Tradonal retard and contents of the package
Hard prolonged-release capsules
Dark green capsules marked withT150SR.
This medicine is in the form of hard prolonged-release capsules. The capsules release the active ingredient over a period of time.
All capsules are packaged in PVC/PVDC-aluminum blisters of 10 capsules. Each package contains 1, 2, 3, 5, 6 or 10 strips of blisters, that is, each package contains 10, 20, 30, 50, 60 or 100 capsules. Some package sizes may only be marketed.
Holder of the Marketing Authorization
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible for manufacturing
Temmler Pharma GmbH
Temmlerstrasse, 2
35039 –Marburg
Germany
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.
C/ General Aranaz, 86
28027 Madrid
Spain
This medicine is authorized in the Member States of the European Economic Area with the following names:
BelgiumTradonal Retard150mg, prolonged-release gelatin capsules
Tradonal Retard150mg, hard capsules with prolonged release
Tradonal Retard150mg, hard capsules with prolonged release, retardiert
DenmarkGemadol Retard
FranceZamudol LP150mg, prolonged-release gelatin capsule
GermanyTravex Retard150mg hard capsules with prolonged release, retardiert
ItalyTradonal SR150mg 30/60 hard prolonged-release capsules
LuxembourgTradonal Retard150mg, prolonged-release gelatin capsules
Tradonal Retard 150 mg, hard capsules with prolonged release
Tradonal Retard 150 mg, hard capsules with prolonged release, retardiert
NetherlandsTramadolHCl Retard Viatris150mg hard capsules with prolonged release
PortugalTravex Hard prolonged-release capsule
SpainTradonal retard150mg hard prolonged-release capsules
United KingdomZamadol SR150mg prolonged-release hard capsule
Date of the last review of this leaflet: May 2024
The detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)(http://www.aemps.gob.es/)
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.